These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 38551494)
1. Diselenide-Containing Polymer Based on New Antitumor Mechanism as Efficient GSH Depletion Agent for Ferroptosis Therapy. Zhou C; Zhao Y; Yang M; Yin W; Li Y; Xiao Y; Liu Y; Lang M Adv Healthc Mater; 2024 Jul; 13(17):e2303896. PubMed ID: 38551494 [TBL] [Abstract][Full Text] [Related]
2. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy. Chen M; Tong X; Sun Y; Dong C; Li C; Wang C; Zhang M; Wen Y; Ye P; Li R; Wan J; Liang S; Shi S Biomaterials; 2024 Sep; 309():122574. PubMed ID: 38670032 [TBL] [Abstract][Full Text] [Related]
3. Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells. Tang H; Chen D; Li C; Zheng C; Wu X; Zhang Y; Song Q; Fei W Int J Pharm; 2019 Dec; 572():118782. PubMed ID: 31678528 [TBL] [Abstract][Full Text] [Related]
4. Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer. Li J; Wu Y; Li Y; Zhu H; Zhang Z; Li Y ACS Nano; 2024 Oct; 18(39):26585-26599. PubMed ID: 39287044 [TBL] [Abstract][Full Text] [Related]
5. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy. Wei Y; Lv H; Shaikh AB; Han W; Hou H; Zhang Z; Wang S; Shang P Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129539. PubMed ID: 31958545 [TBL] [Abstract][Full Text] [Related]
6. Synergistic Effect of Layered Double Hydroxides Nanodosage Form to Induce Apoptosis and Ferroptosis in Breast Cancer. Pang S; Geng C; Fan Z; Hou M; Mao H; Tao S; Wang J; Wu Y; Wei K; Li Y; Yan L; Yang Q; Chen C; Wang W Int J Nanomedicine; 2024; 19():4199-4215. PubMed ID: 38766657 [TBL] [Abstract][Full Text] [Related]
7. Significance of glutathione peroxidase 4 and intracellular iron level in ovarian cancer cells-"utilization" of ferroptosis mechanism. Li D; Zhang M; Chao H Inflamm Res; 2021 Dec; 70(10-12):1177-1189. PubMed ID: 34537856 [TBL] [Abstract][Full Text] [Related]
8. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib. Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851 [TBL] [Abstract][Full Text] [Related]
9. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system. Jin M; Shi C; Li T; Wu Y; Hu C; Huang G Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676 [TBL] [Abstract][Full Text] [Related]
11. Synthetic vectors for activating the driving axis of ferroptosis. Jiang J; Yang L; Xie Q; Liu X; Jiang J; Zhang J; Zhang S; Zheng H; Li W; Cai X; Liu S; Li R Nat Commun; 2024 Sep; 15(1):7923. PubMed ID: 39256387 [TBL] [Abstract][Full Text] [Related]
12. Induction of ferroptosis in human nasopharyngeal cancer cells by cucurbitacin B: molecular mechanism and therapeutic potential. Huang S; Cao B; Zhang J; Feng Y; Wang L; Chen X; Su H; Liao S; Liu J; Yan J; Liang B Cell Death Dis; 2021 Mar; 12(3):237. PubMed ID: 33664249 [TBL] [Abstract][Full Text] [Related]
13. Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis-Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation. Cao W; Zhang X; Feng Y; Li R; Lu A; Li Z; Yu F; Sun L; Wang J; Wang Z; He H ACS Nano; 2024 Jul; 18(26):17267-17281. PubMed ID: 38871478 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of GPX4 or mTOR overcomes resistance to Lapatinib via promoting ferroptosis in NSCLC cells. Ni J; Chen K; Zhang J; Zhang X Biochem Biophys Res Commun; 2021 Aug; 567():154-160. PubMed ID: 34157442 [TBL] [Abstract][Full Text] [Related]
15. Berbamine promotes ferroptosis of esophageal squamous cell carcinoma by facilitating USP51-mediated GPX4 ubiquitination and degradation. Peng H; He Y; Hu Y; Sheng S; Maitiyasen M; Li J; Liu Y; Hou X; Song H; Yi J Biomed Pharmacother; 2024 Oct; 179():117309. PubMed ID: 39151312 [TBL] [Abstract][Full Text] [Related]
16. GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes. Li H; Li Y; Yu Y; Ren X; Yang C; Jin W; Li K; Zhou Y; Wu C; Shen Y; Hu W; Liu Y; Yu L; Tong X; Du J; Wang Y Free Radic Biol Med; 2024 Sep; 222():130-148. PubMed ID: 38866192 [TBL] [Abstract][Full Text] [Related]
17. Targeting PAX8 sensitizes ovarian cancer cells to ferroptosis by inhibiting glutathione synthesis. Luo Y; Liu X; Chen Y; Tang Q; He C; Ding X; Hu J; Cai Z; Li X; Qiao H; Zou Z Apoptosis; 2024 Oct; 29(9-10):1499-1514. PubMed ID: 38853202 [TBL] [Abstract][Full Text] [Related]
18. Ferroptosis model system by the re-expression of BACH1. Irikura R; Nishizawa H; Nakajima K; Yamanaka M; Chen G; Tanaka K; Onodera M; Matsumoto M; Igarashi K J Biochem; 2023 Jul; 174(3):239-252. PubMed ID: 37094356 [TBL] [Abstract][Full Text] [Related]
19. Boswellia carterii n-hexane extract suppresses breast cancer growth via induction of ferroptosis by downregulated GPX4 and upregulated transferrin. Xie J; Huang H; Wei X; Tan P; Ouyang L; Wang L; Liu D; Wang F; Wang Z; Tu P; Li J; Zha X; Hu Z Sci Rep; 2024 Jun; 14(1):14307. PubMed ID: 38906931 [TBL] [Abstract][Full Text] [Related]
20. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells. Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]